Monocyte chemoattractant protein-1 and atherosclerosis: Is there room for an additional biomarker?

This publication has 104 references indexed in Scilit:

• Mechanism of Action of a Distal NF-κB-Dependent Enhancer
  Molecular and Cellular Biology, 2006
• MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
  Journal of Clinical Investigation, 2006
• Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus
  Biochemical and Biophysical Research Communications, 2006
• Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
  The Journal of Experimental Medicine, 2006
• Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters
  International Journal of Obesity, 2006
• Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice
  Biochemical and Biophysical Research Communications, 2006
• CCR2 modulates inflammatory and metabolic effects of high-fat feeding
  Journal of Clinical Investigation, 2006
• Cholesterol-Lowering Independent Regression and Stabilization of Atherosclerotic Lesions by Pravastatin and by Antimonocyte Chemoattractant Protein-1 Therapy in Nonhuman Primates
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
• Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells
  Biochemical and Biophysical Research Communications, 2004
• Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001